The Correlation of Imatinib Therapy Duration and Esti-mated Glomerular Filtration Rate in Chronic Myeloid Leukemia Patients

• Main Authors: Siprianus Ugroseno Yudho Bintoro, Agus Prabowo, Made Putra Sedana, Ami Ashariati Prayoga, Artaria Tjempakasari
• Format: Article PeerReviewed
• Language: English; English; English
• Published: Wolters Kluwer Medknow Publications 2020
• Subjects: R Medicine (General); RC Internal medicine
• Online Access: http://repository.unair.ac.id/96220/1/The%20Correlation%20of%20Imanitib%20Therapy%20duration%20and%20estimated%20glomerular%20filtration%20rate%20in%20chronic%20myeloid%20leukemia%20patients.pdf; http://repository.unair.ac.id/96220/2/The%20Correlation%20of%20Imanitib%20Therapy.pdf; http://repository.unair.ac.id/96220/3/The%20Correlation%20of%20Imanitib%20Therapy%20duration%20and%20estimated%20glomerular%20filtration%20rate%20in%20chronic%20myeloid%20leukemia%20patients.pdf; http://repository.unair.ac.id/96220/; http://www.sysrevpharm.org//index.php?mno=96312; http://dx.doi.org/10.5530/srp.2019.2.04
• Institution: Universitas Airlangga

Chronic myeloid leukemia (CML) is a chronic myeloproliferative dis-ease. Treatment of CML with TKI may cause changes in glomerular filtration rate (GFR) over time. The objective of the study was to analyze the correlation of imatinib therapy duration and eGFR in CML patients in outpatient clinic of...